Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | RECORD-2: Phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma | Ravaud A.; Barrios C.H.; Alekseev B.; Tay M.-H.; Agarwala S.S.; Yalcin S.; CHIA-CHI LIN ; Roman L.; Shkolnik M.; Anak O.; Gogov S.; Pelov D.; Louveau A.-L.; Melichar B. | Annals of Oncology | 66 | 57 |